The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares of a popular, richly priced enterprise, only for the underlying security to suffer due to a poor clinical result. And poor results can happen to anybody, big or small. Indeed,… More
Articles
LIFW Stock Earnings: MSP Recovery Reported Results for Q4 2023
MSP Recovery just reported results for the fourth quarter of 2023. More
LASE Stock Earnings: Laser Photonics Reported Results for Q4 2023
Laser Photonics just reported results for the fourth quarter of 2023. More
SCHW Stock Earnings: Charles Schwab Beats EPS, Beats Revenue for Q1 2024
SCHW stock results show that Charles Schwab beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
INSE Stock Earnings: Inspired Entertainment Beats EPS, Beats Revenue for Q4 2023
INSE stock results show that Inspired Entertainment beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. More
RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023
RVPH stock results show that Reviva Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. More
PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024
PETS stock results show that PetMed Express missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024. More
